RENB - Strategic Colllabaration with Nebul (NVDA) - AI-Biotech
Renovaro Inc. is a biotechnology company specializing in advanced cancer diagnostics and therapeutics. They develop innovative cell and gene therapies to boost the immune system's ability to fight diseases like cancer and HIV. Using artificial intelligence, their technology enables early detection of diseases by analyzing genetic markers. Renovaro aims to revolutionize healthcare with cutting-edge treatments and diagnostics to improve patient outcomes.
Float: 110.363M
Short % of Float: 2.74%
Recent News:
Dec 20, 2024
Renovaro Regains Compliance with NASDAQ Listing Requirement
Renovaro (RENB) announced its subsidiary Renovaro Cube has entered into a strategic collaboration with Nebul to advance the early detection of cancer and other diseases. As part of this initiative, Renovaro Cube plans to deploy a dedicated NVIDIA (NVDA) SuperPOD powered by NVIDIA DGX B200 systems, which feature the latest Blackwell GPU’s, and apply NVIDIA Parabricks functionality to ensure optimal performance on the NVIDIA clusters. Each DGX B200 system delivers up to 72 petaFLOPS of training performance and 144 petaFLOPS of inference performance, providing the computational power necessary to integrate AI across medium-sized hospitals.
Overall Market Sentiment:
It’s always crucial to consider overall market sentiment when making trading decisions.
Trading Strategy:
I consider this a mid- to long-term investment strategy.
Entry:
At recent price around $1.64
Waiting for a pullback into $1.10 zone
Breakout Zone:
$2.00
Resistance Zones:
$2.30
$2.90 - 3.00
$5.00 (double top) - TP 1
$6.80 - 7.20
$8.90 - TP 2
Surpassing these levels could signal a positive trend. Consider taking profits at these levels to realize gains.
Risk/Money Management
Take Profit (TP): Set the final & optimistic target at $13.00
Stop Loss (SL): Set at under $0.95 to mitigate potential losses.
Chart Analysis:
Please refer to the attached chart for detailed analysis of price trends and movements.
Trading Advisory:
Exercise caution and consider market conditions and your own risk tolerance when trading. It's advisable to conduct comprehensive research or consult with a financial advisor before engaging in trading activities.
Disclaimer: This content is for informational purposes only and should not be considered financial advice.
